High expression of CEP55 has been demonstrated to be involved in Fn-infected colon cancer cell growth and cell cycle progression, and could be used as a new diagnostic and prognostic biomarker for Fn-infected CRC. This evidence concerns the gene FN1 and colorectal carcinoma.